{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:18:02Z","timestamp":1787883482500,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/igc.0b013e318280f2b4","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T06:54:18Z","timestamp":1359096858000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?"],"prefix":"10.1016","volume":"23","author":[{"given":"C. Bethan","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramey","family":"Littell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hoodfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318280f2b4_bb0005","first-page":"957","article-title":"Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium","volume":"57","author":"Narod","year":"1995","journal-title":"Am J Hum Genet."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am JHum Genet."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0020","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0025","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am JHum Genet."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0035","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"Hereditary breast and ovarian cancer syndrome. ACOG Practice Bulletin No. 103. American College of Obstetricians and Gynecologists","volume":"113","author":"ACOG","year":"2009","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0050","unstructured":"Myriad Laboratories Annual Report, 2008."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0055","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0060","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0070","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0075","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2002.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"Ben David","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-006-9112-x","article-title":"Improved survival in BRCA2 carriers with ovarian cancer","volume":"6","author":"Pal","year":"2007","journal-title":"Fam Cancer."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0090","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0105","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment of breastandovarianclinicalpracticeguidelinesinoncology. Available at:http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF. Accessed 1 December 2012."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0110","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e318280f2b4_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.10.007","article-title":"Uptake of clinical genetic testing for ovarian cancer in Ontario: a population based study","volume":"112","author":"Metcalfe","year":"2009","journal-title":"Gynecol Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e318280f2b4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:24:29Z","timestamp":1753223069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24018887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1048891X24018887"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318280f2b4","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318280f2b4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}